The mechanism of unidirectional transport of sodium from blood to brain in pentobarbital-anesthetized rats was examined using in situ perfusion. Sodium transport followed Michaelis-Menten saturation kinetics with a V~,,of 50.1 nmol/g/min and a~of 17.7 mM in the left frontal cortex. The kinetic analysis indicated that, at a physiologic sodium concentration,~26% of sodium transport at the blood-brain barrier (BBB) was carrier mediated. Dimethylamiloride (25 pM), an inhibitor of Na~/Hẽxchange, reduced sodium transport by 28%, whereas phenamil (25 pM), a sodium channel inhibitor, reduced the transfer constant for sodium by 22%. Bumetanide (250 pM) and hydrochlorothiazide(1.5 mM), inhibitors of Na-K~-2Cl INaCl symport, were ineffective in reducing blood to brain sodium transport. Acetazolamide (0.25 mM), an inhibitor of carbonic anhydrase, did not change sodium transport at the BBB. Finally, a perfusate pH of 7.0 or 7.8 or a perfusate Pea 2 of 86 mm Hg failed to change sodium transport. These results indicate that 50% of transcellular transport of sodium from blood to brain occurs through Nat/H exchange and a sodium channel in the luminal membrane of the BBB. We propose that the sodium transport systems at the luminal membrane of the BBB, in conjunction with CVIHCO3 exchange, lead to net NaCI secretion and obligate water transport into the brain. Key Words: Brain-Blood-brain barrier-Transport-Sodium-In situ perfusion.
The blood-brain barrier (BBB) serves not only to restrict the movement of water-soluble solutes between blood and brain but also to regulate the ionic composition of the interstitial fluid through transport of Naã nd K (Schielke and Betz, 1993) . Previous reports have provided evidence for both NaCI cotransport and a nonselective sodium channel in the luminal membrane of the BBB (Betz, 1983a) and for an Na~,K~-ATPase and Na*/H+ exchange in the abluminal membrane (Betz, 1983h) . Vigne et al. (1989) , using the patch clamp technique, confirmed that cultured brain endothelial cells contain a nonselective cation channel, but they did not specify the location of the channel to either the luminal or abluminal membrane. On the basis of in vivo studies, Murphy and Johanson (1989) reported that metabolic acidosis and arniloride but not acetazolamide inhibit sodium transport at the BBB, and they postulated an Nat/H exchange mechanism in the luminal membrane. Thus, taken together, the available data suggest the unlikely possibility that the luminal membrane of the BBB contains three different types of sodium transport mechanisms. The present studies were designed to define better the mechanisms of sodium transport at the luminal membrane of the BBB using in situ perfusion of the rat brain. The main advantage of in situ perfusion is that it allows us to control precisely the concentration of inhibitors used to study sodium transport. Finally, because amiloride has affinity for several of the carriermediated sodium transport systems and the sodium channel, we have used the more specific amiloride analogues to characterize sodium transport (Kleyman and Cragoe, 1988) .
Our basic hypothesis was that blood to brain sodium movement is both carrier and channel mediated. The specific questions we sought to answer were the following: (a) Is blood to braid sodium transport subject to saturation kinetics? (b) Is blood to brain sodium transport inhibited by the Na~/Hẽxchange inhibitor dimethylamiloride (DMA), the sodium channel inhibitor phenamil (PAM) (Kleyman and Cragoe, 1988) , the Na~ICl cotransport inhibitors bumetanide and hydrochiorothiazide (HCTZ) (Cremaschi et al., 1992) , or inhibitors of carbonic anhydrase, such as acetazolamide? (c) Is blood to brain sodium transport affected by short-term (~10-min) changes in pH?
Some of' our results were presented in a preliminary communication ( Ennis et al., 1993) .
MATERIALS AND METHODS
'l'ransport of sodium and a-aminoisobutyric acid (AIB) across the BBB was measured using in situ perfusion of rat brain, as previously described (Ennis et al.. 1994) . In brief, stale, Long-Evans rats, weighing 300-450 g, were anesthetied with pentoharbital (65 mg/kg). The right and left comittun carotid and pterygopalatine arteries were isolated, and tl~~terygopalatinc arteries were ligated. Catheters of PE-5)) tubing, filled with heparinized saline, were placed in the lell fumoral artery and in the left external carotid artery. Rats were hepariniied (1.2 untts/g of body weight), and samples br blood gases obtained from the left b'emoral artet'y. The belt external carotid artery cannula was used for retrograde p~rbusionof sheep red blood cells (RBCs) in saline at a telilperatLtre of 37°C.The perfusate was infused at a rate of 4 uI/mm. We have previously shown that this perfusion rate is adequate for maintenance of the EEG (Ennis et al., 1994) . A hematocrit of 0.3-0.35 was used for these studies. A uutixtut-e of 30% oxygen and 70% air was delivered by face iui:tsk to improve oxygenation of animals during the preperItusion period. Femoral and carotid blood pressures were c alit inuously u'ecorded through transducers connected to the :tu-terial catheters. Blood pressure and EEG were recorded using a Biopac MPIOO data acquisition system. The body teuuperatLtre was maintatned between 37.5 and 38.5°Cusing a rectal Thermistor connected to a temperature monitor/con-
Measurement of blood to brain transport during in situ perfusion
Blood to brain permeability-surface area products (PS prodLicts) for I 5H IAIB (0.5 pCi/mI), a marker for passive )eu'tneahulity, and ::Na~(0.5 pCi/mI) were determined using I 0-mm perfusion. We have provided evidence that in the pi-esence of 2 mM phenylalanine the transport of AIB from blood to brain occurs only by passive transport drtring the It) ruin used for current in situ perfusion experiments (Ennis et al., 1994) . The PS product for [1H]AIB was measured for all animals in this study. Supplemental pentobarhital (22 tug/kg) was given Just before perfusion to prevent the aniitials awakening during the perfusion. Following the perfusion, the brain was removed, and the hemispheres were bisected and dissected into frontal, parietal, and occipital cortiecs and diencephalon. Brain and perfusion fluid samples were dissolved in rnethylbenzthonium hydroxide and prepared for liquid scintillation counting.
('omposition of perfusion fluids
Blood was stored at 4°Cuntil the day of use. Whole blood was centrifuged at 1,660 g for 10 mm at 8°C.and the plasma itid white blood cells were discarded. The lightly packed R RCs were washed twice by centrifugation in 1,5 volumes of 0.9% NaCI and twice by centrifugation in 1.5 volumes of perfusate saline. After the final spin, the RBCs were filtered thi'ough nylon mesh (pot-c size, ISO pm) and resuspended at a hematocrit of 0.3 in the perfusate. The composition of the control saline used to make the RBC-containing perfusate was 118 mM NaCI, 3 mM KCI, 1.2 mM MgSO 4, 1.2 mM KH:P04. 24 mM NaHCO5, 2.5 mM CaC12, 10 mM glucose, and 2 mM phenylalanine. The perfusate containing radioactive isotopes was gently bubbled with a mixture of oxygen and carbon dioxide to maintain the pH in the range 7.35-7.45. Inhibitors of ion transport were dissolved in saline and included in the final perfusate at the concentrations given in the text.
The perfusates with a reduced sodium concentration were mixtures ot' Tris-HCI, Tris-base, and 24 mM Tris-carhonate as substitutes for NaCI and NaHCO3. Sodium and potassium concentrations were confirmed using a flame photometer (IL 943), and chloride levels were measured using a chloridometer (Haake-Buchler Instruments).
Normocapnic perfusates with either a low or high pH were ci'eated by changing the amount of NaHCO~,along with appropriate changes in the amount of NaCI included in the perfusate, to maintain a constant osmolality. The low pH perfusate contained 130 mM NaCI, 3 mM KCI, 1.2 niM MgSO., 1.2 mM KH2PO4, 9.98 mM NaHCO5, 2.5 mM CaCL, 10 mM glucose. and 2 mM phenylalanine with a pH of 7.01 ±0.01. The high pH perfusate contained 77 mM NaCI, 3 mM KCI, 1.2 mM MgSO4, 1.2 mM KH2PO4, 62.9 mM NaHCO1, 2.5 mM CaCI2. 10 mM glucose, and 2 mM phenylalanine with a pH of 7.76 ±0.01. The hypercapnic perfusate. with a normal pH, contained 91.9 mM NaCI. 3 mM KCI. 1.2 mM MgSO4, 1.2 mM KH2PO4, 50.1 mM NaHCO~,2.5 mM CaCl2, 10 mM glucose, and 2 mM phenylalanine with apH of 7.35 ±0.01 and Pco2 of 85.6 ± 1.61 mm Hg.
Calculation of rate constants for BBB permeability to AIB and NaT he rate constant for movement of solute across the BBB was calculated from the following equation:
where A1, is the amount of solute in the brain per unit mass of tissue (dpm/g), C1, is the perfusate solute concentration (dpm/ml), and T is time. In the present experiments C~is constant.
The K, values measured in this study were <1% of the rate of blood flow that we reported pi'eviously for in situ perfusion of the rat brain (Ennis et al., 1994) . Consequently, K, closely approximates the PS product as described by Fenstermacher et al. (1981) . The PS produt~tfor a substance at the BBB is the product of the permeability (I') (cnilmin) and the surface area (S) (cm~/g).
Uptake data were corrected for the amount of tracer that remains within the vascular space of the brain by the following equation:
where the pCI'V is the perfusate cerebral plasma volume. An average pCPV in the present study was determined in separate groups of animals, from the amount of LH]inulin in the brain samples (assuming no tissue uptake). The transfer constant for sodium was also determined from a multiple time/graphical analysis. The following equation describes the relationship between the amount of tracer in the brain (A1,) and its concentration in plasma:
where V~, is the sum of the plasma and rapidly filling spaces (V5 = pCPV + Vr). V5 is termed the rapidly filling space because it rapidly and reversibly exchanges with plasma (Patlak eta!., 1983) . Under initial velocity conditions, a plot of A 5/C~,(T)versus perfusion time is a straight line with the slope = K, and the v-intercept = V1,.
The time of isotope circulation ranged between 6 and 18 mm. The transfer constant for sodium was measured in two groups of animals: (a) animals perfused with sheep RBCs in a saline containing a physiological sodium concentration (n = 11) and (b) animals perfused with sheep RBCs in a saline containing a low sodium concentration (0.2 mM) (n = 10).
Kinetics of transport from perfusate to brain
Carrier-mediated, unidirectional influx at the BBB is commonly described by the Michaelis-Menten equation (Pardridge, 1983) . Because v = PS x C, where v is the velocity of transport and C is concentration, then (4) where V,~,5is the maximal velocity of transport, K~,is the affinity constant, and KD is the diffusion constant. When K, PS. the capillary concentration does not change appreciably as a result of uptake into the brain, and C~approximates the mean capillary concentration.
Carrier-mediated sodium uptake across the BBB was investigated in a group of 22 animals in which perfusate sodium concentration was varied between 0.5 and 137 mM. The PS products for both [ 3HIAIB and 22Na were measured in these animals. The data were fitted to Eq. 4 using nonlinear regression analysis.
Perfusate cerebral blood flow (,pCBF)
The pCBF was calculated using '4C-labeled iodoantipyrine as the blood flow indicator. The uptake of iodoantipyrine is flow-limited at a pCBF of <1.8 ml/g/min (Sakurada et al., 1978) . Under these conditions, the pCBF was calculated as follows:
Animals were preperfused for 10 mm with the appropriate solution before the pCBF was determined. Radiolabeled iodoantipyrine was perfused into the external carotid artery for 15 s to measure pCBP.
Statistical analysis
Data for single time point PS products (Eq. 1) were analyzed using a model 1 ANOVA with either an unpaired, two tailed t test or with a two-tailed Dunnett's post hoc test for multiple comparisons. The Systat statistical software was used for these comparisons. Transfer constants using a graphical analysis were calculated by least squares regression analysis of the data fit to Eq. 3. The results were subjected to an analysis of covariance with a two-tailed t test. The transport constants for Eq. 4 were calculated by a nonlinear, least squares regression analysis, using the BMDP-3R program. A p value of <0.05 was considered significant. Perfusion pressure is the carotid pressure minus the pressure due to the carotid cannula. Table 1 presents the average values for blood gases, physiological parameters, and plasma osmolality and sodium, potassium, and glucose concentrations. These data were measured just before the beginning of a perfusion. These parameters were measured for the (5) perfusate and are also included in Table 1 . Perfusions in which the sodium concentration was manipulated are not included in Table I . The values for these all parameters were significantly different (p~0.001) between plasma and perfusate. Before starting these experiments we realized it would not be possible to match plasma and perfusate exactly and chose to set the values for the perfusate as presented in Table I . The small differences between plasma and perfusate are probably not physiologically significant. Patlak et al. (1983) have shown that the use of graphical analysis of multiple-time uptake data allows the evaluation of the unidirectionality of transport and the influx rate constant, without the need for a correction for the vascular space. We used this method in our initial determination of the rate constant for Naĩ nflux across the BBB. Figure I presents a graphical analysis for Na~uptake in the frontal cortex using in situ perfusion with a perfusate containing either a normal (138 mM) or a low (0. t-eniained unidirectional. The transfer constant for Nad uring perfusion with a normal sodium concentration was 1.1 ±0.2 pl/g/mmn with a rapidly filling space of 5.3 ± 2.8 p11g. Data are mean ± SE values. The transl'er constant during in situ perfusion with a low odium perfusate was significantly increased (p 0.001 by !test) to 3.2 ±0.4 pllglmmn, as anticipated 'or carrier-mediated transport at the BBB. Carrier-mediated transport is subject to self-inhibition, and therefore a low sodium concentration should result in a significant increase in the transfer constant for sodium. l'hese results confirm carrier-mediated transport for sodium at the BBB. In addition, the demonstration of unidirectional sodium transport during a 20-mm perfusion validates the use of 10-mm, single time point stitdies for the remainder of this study. Figure 2A presents the sodium PS product as a function of the sodium concentration in the perfusate. These data were best fit by nonlinear least squares regression Multiplying the PS product for sodium by its concentration, C, in the perfusate gives the unidirectional flux. Figure 2B shows the total sodium flux into the brain as a function of perfusate sodium concentration. Also presented are the curves describing the carriermediated fraction and the nonsaturable portion of the total flux that moves by diffusion, either through ion channels or through membrane pores. At a soditim concentration of 140 mM the carrier-mediated fraction represents '~28%of the total flux.
Chemicals and radiotracers

RESULTS
Graphical analysis of sodium transport
Kinetics of sodium transport in the frontal cortex
inhibition of blood to brain sod!um transport
The advent of the new generation of more specific amiloride analogues permits the identification of vanotis Na transport processes (Kleyman and Cragoe, 1988) . Figure 3 presents data on the effect of the amibride analogues DMA and PAM on the PS products for AIB and Na~products during a ID-mm perfusion. DMA, an inhibitor of Na /H 0 exchange, at a concen- In contrast to the amiloride analogues, inhibitors of Na 1 IK~/2CL or NaCI symport were ineffective in reducing blood to brain sodium transport. Table 2 presents data for the effect of' these inhibitors on sodium transport during in situ perfusion. The relatively high concentrations of 250 pM bumetanide or 1.5 mM HCTZ were without effect on sodium or AIB uptake. Figure 4 presents the effect of acetazolamide (0.25 mM) included in the perfusate during a 10-mm expeni-.1. Neuros'Iss'n,.. Vol. 66, No. 2. 1996 ment. Acetazolamide could lead to a decrease in the sodium PS product through an inhibition of carbonic anhydrase present in the brain capillary endothelial cells (Ghandour et al., 1992) . Inhibition of carbonic anhydrase could lead to an increase in the pH of the brain capillary endothelial cell. This change in cellular pH cotild decrease the H~gradient across the luminal membrane of the brain capillary endothelial cell (from cell to blood) and result in an inhibition of Na~/Hẽ xchange. Acetazolamide at this concentration had no effect on either the sodium PS or AIB PS product. Also included in the legend for Fig. 4 are the pH and Pco 2 for the control and acetazolamide-containing perfusates. There were no significant differences in these parameters.
The presence of DMA-sensitive Na I IH~exchange at the BBB led us to hypothesize that a decrease in blood pH would decrease the sodium PS product by decreasing the H I gradient across the luminal membrane of the brain capillary endothelial cell. Using similar reasoning we speculated that an increase in blood pH might stimulate Na~transport by increasing the W gradient from the capillary endothelial cell to blood. Table 3 shows that perfusion of the brain with normocapnic blood at a pH of 7.0 or 7.76 did not result in a change in either the AIB or sodium PS product.
Also presented in Table 3 is an experiment in which the pH was normal at a value of 7.4 but the PCO2 was increased to 86 mm Hg. An increase in blood PC02 failed to increase significantly the sodium PS product.
We expected that an increase in the H + concentration within the capillary endothelial cells due to the action of carbonic anhydrase on the increased CO2 level would stimulate transport through the Na~/H~ex-changer in the luminal membrane. We speculate that   FIG. 4 . Effect of acetazolamide on the AIB and Na PS products or the ratio of Na/AIB. Acetazolamide (0.25 mM) was included in the perfusate during a 10-mm perfusion. Groups were compared using an unpaired ttest. Data are mean ±SE (bars) values. the increase in the PCO2 of the perfusate during the 10-mm perfusion did not lead to a significant increase in the H + concentration of the brain endothelial cell.
There was a small, <9 mm Hg, difference in the PCO2 of the control and low pH perfusates. This difference was not considered important because a 52 mm Hg increase in the PCO2 did not significantly change the sodium PS product.
Cerebral plasma volume and blood flow
The calculation of an accurate PS product requires the determination of the plasma volume (Eq. 2). The pCPV and the pCBF for experimental conditions and substances that were thought to have potential for changing pCPV and pCBF are presented in Table 4 . Only the normocapnic perfusate with a pH of 7.76 resulted in a significant change in the pCPV.
The pCBE was significantly increased by a hypercapnic (PC02 = 84 mm Hg) perfusate with a physiological pH (7.38) by 65% (p 0.001). Current evidence supports the idea that an increase in blood PCO2 results in a decrease in the pH of the extracellular fluid of the brain, causing a vasodilatation and an increase in the cerebral blood flow (Siesjo and Ingvar, 1983) . Similarly, a normocapnic perfusate with a pH of 7.03 also significantly increased (p~0.001) the pCBF, probably through an increase in the H~content of the interstitial fluid of the brain. Again, there was a small increase in the PCO2 of the low pH perfusate, which we did not consider physiologically relevant.
The pCBF was also increased by acetazolamide (I mM), from 1.03 ±0.04 ml/g/min for control animals to I .34 ±0.04 ml/g/min for treated animals. Acetazolamide is thought to lead to cerebral hypercapnia and extraceblular acidosis (Bickler et al., 1988) . The effect of 25 pM DMA in the perfusate is also included in Table 4 . Because this concentration of DMA produced a 28% decrease in the sodium PS product, we thought that the pH of the'brain capillary endothelial might also decrease and lead to an increase in the pCBF. DMA had no significant effect on the pCBF, which may indicate that a larger change in pH is required to increase cerebral blood flow. These results on pCBF indicate that the perfused rat brain is able to respond in a physiological fashion to known stimuli and confirm the viability of the preparation.
DISCUSSION
We have shown previously that in situ perfusion using sheep RBCs maintains the EEG and the pCPV and pCBF within the normal range of in vivo values, indicating that the technique provides adequate perfusion of the rat brain (Ennis et al., 1994) . All of the animals in the present study had an intact EEG during the time course of a perfusion.
Sodium transport from blood to brain
The mechanisms of blood to brain sodium transport are not well characterized. It has been proposed that blood to brain sodium movement is by diffusion lhrough neutral pores in the paracellular pathway, based on symmetrical diffusion potentials and the lack of' selectivity to Nat, K~,and C1 (Crone, 1984) . The very low permeability of sodium at the BBB was resolved through postulating a small number of these pores (Crone, 1984) . Damage to the microvessels during these experiments and the observation that K~ex-Itihits a seven to 10 times higher permeability at the I3BB than Na~were cited as evidence against the hy1othesis that pores provide the major route for ion transport across the BBB (Schielke and Betz, 1993) . Using in situ perfusion we have studied sodium transPort at the luminal membrane of the BBB with a technique that is not hampered by the limitations of other methods (Takasato et al., 1984; Ennis et al., 1994) .
'ihe main advantage of in situ perfusion is the ability to study unidirectional transport at a constant blood low, with a perfusate of known composition. As an example, the only previous determination of the kinetics of sodium transport from blood to brain used the intracarotid single injection technique (Betz, l983a). 'l'he kinetics of sodium transport were determined relalive to those of L-glucose and showed a K~, of 2.5 mM. This value for the K,,, is a factor of 8 less than the 17.7 mM from present study and probably reflects the mixing of a bolus injection with blood (Pardridge, l')83).
It is interesting that at a sodium concentration of 140 mM, the carrier-mediated portion of sodium flux represents 26% of the total flux, which is very similar to the 28% inhibition that results from including 25 pM DMA in the perfusate. The similarity between these numbers suggests that 25 p.M DMA completely inhibits the luminal Na~/Hẽxchanger. The K,,,, determined from the kinetics of sodium transport, of 17.7 mM is within the range of values of 15-18 mM characteristic of the different isoforms of Na~/H~ex-changers (Levine et al., 1993) .
Another 22% of the unidirectional sodium flux is mediated by a PAM-sensitive transport system. A PAM-sensitive, nonselective cation channel with a conductance of 23 pS has been reported in cultured brain microvascular cells (Vigne et al., 1989) . A nonselective cation channel with similar biophysical properties that is inhibited by atrial natriuretic peptide, intracellular cyclic GMP, and cyclic GMP kinase has also been reported in inner medullary collecting duct (Light et al., 1990) . The luminal membrane of brain capillaries contains atrial natriuretic peptide receptors (Ermisch et al., 1991) coupled to guanylate cyclase (Steardo and Nathanson, 1987) . Atrial natriuretic peptide inhibits amiloride-sensitive sodium transport in isolated brain capillaries (Ibaragi et al., 1989) .
Metabolic acidosis and alkalosis and a respiratory acidosis were all ineffective in changing the rate of sodium transport from blood to brain during a 10-mm exposure. In contrast, other investigators have presented evidence that a metabolic acidosis of 1 h in duration reduced the sodium PS product by 25% (Murphy and Johanson, 1989) . The time of exposure to the altered blood pH is the main difference between these studies and probably accounts for the different results.
Recently the isoform of carbonic anhydrase desig- These transport systems, along with the Nat, K~-ATPase located in the basolateral membrane of the BBB. are thought to provide the driving force for net sodium and water secretion (Schielke and Betz, 1993) . Figure 5 presents our current model for sodium transport at the BBB. We have included a CL/HCO 3 exchanger in the luminal membrane that requires experimental verification. This transport system along with the DMA-sensitive Na' !H 0 exchanger would lead to neutral NaCI transport across the BBB, as occurs in epithelia (Cremaschi et al., 1992) . Our reasoning is that simultaneous Na~/Hãnd CL/HCO 3 exchange could provide for coupling between Na~and Cl transport as has been shown for epithelia (Cremaschi et al., 1992) . In addition, other investigators have shown carrier-mediated chloride transport at the BBB that is not linked to Na~transport .
The model also includes an Na~/H 0exchanger in the abluminal membrane. This transport system was identified from the effect of amiloride on isolated rat brain capillaries (Betz, 1983h) . The Na~/H0 exchangers are recognized as a gene family consisting of at least four isoforms, designated NHE 1 -4. NHE I is probably expressed in all mammalian cells, located in the hasolateral membrane and functions in pH and volume regulation. In contrast, NHE 3 is thought to reside primarily in the apical membranes in epithelial cells and to function in neutral NaCI transport involving a CL!HCO~exchanger (Levine et al., 1993; Tse et al., I 993a,h) . It is an attractive hypothesis to suggest that the brain capillary endothelium may also have asymmetrical expression of the Na '/H ' exchange isoforms based on similar functional considerations.
Our data suggest that the DMA-sensitive Na /H' exchanger and the PAM-sensitive soditim channel are located in the luminal membrane of the BBB. The low concentrations used, combined with the very short exposure time of 10 mm, would most likely not allow either DMA or PAM to penetrate into the brain extracellular space to a sufficiently high concentration to inhibit Natransport at the abluminal membrane. Furthermore, these low concentrations should not inhibit other cellular process such as the Na K' -ATPase or oxidative metabolism (Frelin et al., 1988; Kleyman and Cragoc, 1988) . The observation that DMA and PAM reduce blood to brain sodium transport suggests that the luminal membrane may be rate limiting for transendothelial transport of sodium. Confirmation of our speculation on the location of these transport systems in the luminal membrane of the BBB will require further experiments such as immunohistochemistry with specific antibodies to identify these proteins as has been done for CA IV (Ghandotir et al., 1992) or the glucose transporter (Gerhart et al., 1989) .
Improved knowledge of the mechanisms of ion transport may allow the use of specific drug therapy to reduce edema formation during the early phase of focal cerebral ischemia (Betz et al., 1989h ). The first 6 h of cerebral ischemia is characterized by a net increase in content of brain cations that accounts for the net increase in brain water (Young et al.. 1987; Betz et al., 1989a; Menzies et al., 1993) . Furthermore, the rate of sodium transport appears to be selectively increased during this period of ischemia (Ennis et al., 1990; Schielke et al., 1991; Dickinson and Betz. 1992 ) through a stimulation of Na ',K ' -ATPase (Schielke et al., 1991) . The more specific amiloride analogues may permit targeting of these sodium transport systems to reduce edema formation during focal cerebral ischemia.
